Skip to main content
. 2017 Jan 4;2(1):85–93. doi: 10.1016/j.adro.2016.12.003

Table 4.

Patient information

Dose Level Age (y) Sex Histology Grade Initial Size(cm) Preoperative Size (cm) Organs resected Margins (mm) Necrosis/Fibrosis (%) Follow-up (mo) LC DM Status
1 67 F LMS 2 17.7 17.1 2 <1 25 34 Yes No NED
1 69 M LMS 2 16.1 15.9 2 1 20 33 Yes Yes AWD
1 62 M Spindle 2 19.8 22.9 No op No op No op 6 NA Yes DOD
1 55 F DDLS 2 23.2 22.3 6 +WDLS 50 24 Yes No NED
2 54 M DDLS 2 21.4 20.2 4 1 15 21 Yes No NED
2 67 M DDLS 3 13.9 15.9 No op No op No op 6 NA Yes DOD
2 62 F LMS 2 10.6 8.1 5 + 15 18 Yes Yes AWD
2 70 F DDLS 2 14.0 16 2 +WD/DDLS 15 12 Yes No NED
3 66 F DDLS 2 17.4 16 3 +WD/DDLS 5 6 Yes No NED
3 52 M DDLS 2 26.3 27.8 3 +WDLS 50 4 Yes No NED
3 74 M WDLS 1 14.6 12.7 0 +WDLS 0 1 Yes No NED

AWD, alive with disease; DDLS, dedifferentiated liposarcoma; DM, distant metastases; DOD, dead of disease; LC, local control; LMS, leiomyosarcoma; NED, no evidence of disease; op, operation; WDLS, well-differentiated liposarcoma.